Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 10.41% is 18% above its 5-year average of 8.82%, near the high end of its 5-year range (7.07%–10.41%).
As of the fiscal period ended Friday, July 31, 2026. 5.89% above its 12-month average of 9.83%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q1 FY2027 (2026-07-31): 10.41%.
RETURN ON EQUITY (ROE)
10.41%
RETURN ON EQUITY (ROE) AVG TTM
9.83%
RETURN ON EQUITY (ROE) AVG 3Y
8.99%
RETURN ON EQUITY (ROE) AVG 5Y
8.82%
RETURN ON EQUITY (ROE) AVG 10Y
8.35%
RETURN ON EQUITY (ROE) AVG 15Y
8.13%
RETURN ON EQUITY (ROE) AVG 20Y
13.19%
CURRENT VS TTM AVG
+5.89%
CURRENT VS 3Y AVG
+15.87%
CURRENT VS 5Y AVG
+18.11%
CURRENT VS 10Y AVG
+24.64%
CURRENT VS 15Y AVG
+28.00%
CURRENT VS 20Y AVG
-21.04%
SECTOR MEDIAN · HEALTHCARE
13.01%
median of 84 covered companies
CURRENT VS SECTOR MEDIAN
-19.97%
vs the sector median at left
Medtronic plc
Market Cap
$120.00B
Return on Equity (ROE)
10.41%
TTM Avg
9.83%
3Y Avg
8.99%
5Y Avg
8.82%
Market Cap
$120.56B
Return on Equity (ROE)
6.16%
TTM Avg
4.23%
3Y Avg
6.35%
5Y Avg
7.74%
Market Cap
$130.18B
Return on Equity (ROE)
41.59%
TTM Avg
-8.30%
3Y Avg
7.76%
5Y Avg
4.45%
Market Cap
$130.62B
Return on Equity (ROE)
21.76%
TTM Avg
8.96%
3Y Avg
15.60%
5Y Avg
19.47%
Market Cap
$107.92B
Return on Equity (ROE)
15.55%
TTM Avg
14.50%
3Y Avg
15.05%
5Y Avg
14.30%
Market Cap
$133.24B
Return on Equity (ROE)
17.28%
TTM Avg
15.07%
3Y Avg
13.91%
5Y Avg
13.46%
Market Cap
$105.32B
Return on Equity (ROE)
N/A
TTM Avg
-189.06%
3Y Avg
-180.53%
5Y Avg
3473.86%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medtronic plc (MDT) | $120.00B | 10.41% | 9.83% | 8.99% | 8.82% |
| CVS Health Corp. (CVS)vs › | $120.56B | 6.16% | 4.23% | 6.35% | 7.74% |
| Bristol-Myers Squibb Company (BMY)vs › | $130.18B | 41.59% | -8.30% | 7.76% | 4.45% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $130.62B | 21.76% | 8.96% | 15.60% | 19.47% |
| Stryker Corporation (SYK)vs › | $107.92B | 15.55% | 14.50% | 15.05% | 14.30% |
| Intuitive Surgical, Inc. (ISRG)vs › | $133.24B | 17.28% | 15.07% | 13.91% | 13.46% |
| McKesson Corporation (MCK)vs › | $105.32B | N/A | -189.06% | -180.53% | 3473.86% |
| Sanofi (SNY)vs › | $101.81B | 5.82% | 9.06% | 9.15% | 10.86% |
| GSK plc (GSK)vs › | $100.20B | 27.67% | 26.90% | 55.97% | 45.70% |
| Danaher Corporation (DHR)vs › | $147.13B | 7.61% | 7.38% | 9.51% | 10.24% |
ROE
10.4%
ROA
5.6%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-07-31 | 10.41% |
| 2026-04-24 | 9.70% |
| 2026-01-23 | 9.42% |
| 2025-10-24 | 9.79% |
| 2025-07-25 | 9.73% |
| 2025-04-25 | 9.71% |
| 2025-01-24 | 8.63% |
| 2024-10-25 | 8.84% |
| 2024-07-26 | 8.19% |
| 2024-04-26 | 7.32% |
| 2024-01-26 | 8.11% |
| 2023-10-27 | 7.97% |
| 2023-07-28 | 7.07% |
| 2023-04-28 | 7.30% |
| 2023-01-27 | 7.90% |
| 2022-10-28 | 8.33% |
| 2022-07-29 | 9.88% |
| 2022-04-29 | 9.59% |
| 2022-01-28 | 9.35% |
| 2021-10-29 | 9.05% |
| 2021-07-30 | 7.54% |
| 2021-04-30 | 7.01% |
| 2021-01-29 | 5.70% |
| 2020-10-30 | 7.05% |
| 2020-07-31 | 8.77% |
| 2020-04-24 | 9.44% |
| 2020-01-24 | 10.26% |
| 2019-10-25 | 9.23% |
| 2019-07-26 | 8.78% |
| 2019-04-26 | 9.25% |
| 2019-01-25 | 9.87% |
| 2018-10-26 | 4.56% |
| 2018-07-27 | 6.30% |
| 2018-04-27 | 6.12% |
| 2018-01-26 | 5.59% |
| 2017-10-27 | 9.75% |
| 2017-07-28 | 8.12% |
| 2017-04-28 | 8.01% |
| 2017-01-27 | 8.04% |
| 2016-10-28 | 8.45% |
| 2016-07-29 | 7.18% |
| 2016-04-29 | 6.83% |
| 2016-01-29 | 4.79% |
| 2015-10-30 | 4.43% |
| 2015-07-31 | 4.97% |
| 2015-04-24 | 5.03% |
| 2015-01-23 | 15.49% |
| 2014-10-31 | 14.97% |
| 2014-07-31 | 15.50% |
| 2014-04-30 | 15.76% |
| 2014-01-31 | 18.53% |
| 2013-10-31 | 20.34% |
| 2013-07-31 | 19.20% |
| 2013-04-30 | 18.57% |
| 2013-01-31 | 19.56% |
| 2012-10-31 | 20.01% |
| 2012-07-31 | 21.22% |
| 2012-04-30 | 21.14% |
| 2012-01-31 | 19.82% |
| 2011-10-31 | 20.26% |
| 2011-07-31 | 18.89% |
| 2011-04-30 | 19.39% |
| 2011-01-31 | 21.32% |
| 2010-10-31 | 21.46% |
| 2010-07-31 | 23.85% |
| 2010-04-30 | 21.18% |
| 2010-01-31 | 15.87% |
| 2009-10-31 | 15.72% |
| 2009-07-31 | 13.83% |
| 2009-04-30 | 16.31% |
| 2009-01-31 | 21.29% |
| 2008-10-31 | 17.11% |
| 2008-07-31 | 18.62% |
| 2008-04-30 | 19.34% |
| 2008-01-31 | 20.34% |
| 2007-10-31 | 24.95% |
| 2007-07-31 | 25.83% |
| 2007-04-30 | 25.53% |
| 2007-01-31 | 24.85% |
| 2006-10-31 | 26.17% |
| 2006-07-31 | 28.55% |
| 2006-04-30 | 27.14% |
| 2006-01-31 | 17.05% |
| 2005-10-31 | 16.85% |
| 2005-07-31 | 15.07% |
| 2005-04-30 | 17.26% |
| 2005-01-31 | 21.29% |
| 2004-10-31 | 21.14% |
| 2004-07-31 | 21.58% |
| 2004-04-30 | 21.59% |
| 2004-01-31 | 21.61% |
| 2003-10-31 | 22.18% |
| 2003-07-31 | 20.39% |
